Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. [electronic resource]
Producer: 20121018Description: 825-32 p. digitalISSN:- 1556-1380
- Adenocarcinoma -- mortality
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- mortality
- Carcinoma, Squamous Cell -- mortality
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Cross-Sectional Studies
- Deoxycytidine -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Humans
- Lung Neoplasms -- mortality
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Prognosis
- Survival Rate
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.